Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Little oversight, enforcement and monitoring of home demolitions in Idaho with asbestos could threaten community health ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... in combination with inhaled corticosteroids (ICS), so ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

They provided evidence to guide treatment decisions for COPD patients. Study: Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...